Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-21-028165
Filing Date
2021-05-20
Accepted
2021-05-20 16:15:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea141344-424b3_citiuspharma.htm 424B3 216620
2 GRAPHIC image_001.jpg GRAPHIC 13550
  Complete submission text file 0001213900-21-028165.txt   236591
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-256063 | Film No.: 21944650
SIC: 2834 Pharmaceutical Preparations